Title
Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study
Date Issued
01 December 2019
Access level
open access
Resource Type
journal article
Author(s)
Castillo P.
Fernandes F.
Navarro M.
Lovane L.
Casas I.
Quintó L.
Marco F.
Jordao D.
Ismail M.R.
Lorenzoni C.
Martinez-Palhares A.E.
Ferreira L.
Lacerda M.
Monteiro W.
Sanz A.
Letang E.
Marimon L.
Jesri S.
Cossa A.
Mandomando I.
Vila J.
Bassat Q.
Ordi J.
Menéndez C.
Carrilho C.
Martínez M.J.
Universidad de Barcelona
Publisher(s)
Nature Publishing Group
Abstract
Cryptococcosis is a major opportunistic infection and is one of the leading causes of death in adults living with HIV in sub-Saharan Africa. Recent estimates indicate that more than 130,000 people may die annually of cryptococcal meningitis in this region. Although complete diagnostic autopsy (CDA) is considered the gold standard for determining the cause of death, it is seldom performed in low income settings. In this study, a CDA was performed in 284 deceased patients from Mozambique (n = 223) and Brazil (n = 61). In depth histopathological and microbiological analyses were carried out in all cases dying of cryptococcosis. We determined the cryptococcal species, the molecular and sero-mating types and antifungal susceptibility. We also described the organs affected and reviewed the clinical presentation and patient management. Among the 284 cases included, 17 fatal cryptococcal infections were diagnosed. Cryptococcus was responsible for 16 deaths among the 163 HIV-positive patients (10%; 95%CI: 6–15%), including four maternal deaths. One third of the cases corresponded to C. gattii (VGI and VGIV molecular types, Bα and Cα strains) and the remaining infections typed were caused by C. neoformans var. Grubii (all VNI and Aα strains). The level of pre-mortem clinical suspicion was low (7/17, 41%), and 7/17 patients (41%) died within the first 72 hours of admission. Cryptococcosis was responsible for a significant proportion of AIDS-related mortality. The clinical diagnosis and patient management were inadequate, supporting the need for cryptococcal screening for early detection of the disease. This is the first report of the presence of C. gattii infection in Mozambique.
Volume
9
Issue
1
Language
English
OCDE Knowledge area
Enfermedades infecciosas Otras ciencias médicas
Scopus EID
2-s2.0-85065823995
PubMed ID
Source
Scientific Reports
ISSN of the container
20452322
Sponsor(s)
We would like to thank the families of the deceased patients included in this study. The authors are grateful to all the members of the Department of Pathology of Maputo Central Hospital and Department of Pathology of Fundação de Medicina Tropical Doutor Heitor Viera Dourado, whose support made this study possible, and to the staff of the Centro de Investigação em Saúde de Manhiça (CISM) for their logistic support. We specifically thank Mr. Bento Nhancale for his invaluable support to the study. We thank Dr. Sean Zhang (Mycology Laboratory, Department of Pathology, The Johns Hopkins University School of Medicine) for kindly providing the IGS sequences of the Cryptococcus reference strains and IMMY (OK, U.S.A) for providing the CrAg LFA tests. We also thank the European Society for Clinical Microbiology and Infectious Diseases Study Group for Forensic and Postmortem Microbiology (ESGFOR) for valuable training and advice. The CaDMIA research project (Validation of the minimally invasive autopsy tool for cause of death investigation in developing countries) was funded by the Bill & Melinda Gates Foundation (Global Health grant numbers OPP1067522; QB) (http://www.gatesfoundation.org/) and by the Spanish Instituto de Salud Carlos III (FIS, PI12/00757; CM) (https://portalfis.isciii.es). Data analysis has been supported by the CaDMIA plus research project, funded by the Bill & Melinda Gates Foundation (Global health grant numbers OPP1128001; JO) (http://www.gatesfoundation. org) and the Spanish Instituto de Salud Carlos III (Acciones CIBER; CM) (http://www.ciberisciii.es/). This study was partially supported by the Agència de gestió Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) -Departament d’Empresa i Coneixement. Generalitat de Catalunya [2017 SGR 794 to M.J.M.]. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya (http://cerca.cat/en/suma/). CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Sources of information: Directorio de Producción Científica Scopus